Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$46.82 - $76.2 $18,728 - $30,480
-400 Reduced 1.67%
23,500 $1.14 Million
Q3 2022

Feb 14, 2023

BUY
$70.55 - $111.58 $853,655 - $1.35 Million
12,100 Added 102.54%
23,900 $1.69 Million
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $853,655 - $1.35 Million
12,100 Added 102.54%
23,900 $1.69 Million
Q2 2022

Feb 14, 2023

SELL
$50.24 - $80.48 $170,816 - $273,632
-3,400 Reduced 22.37%
11,800 $836,000
Q2 2022

Aug 15, 2022

SELL
$50.24 - $80.48 $170,816 - $273,632
-3,400 Reduced 22.37%
11,800 $837,000
Q1 2022

Feb 14, 2023

SELL
$57.98 - $93.5 $504,426 - $813,450
-8,700 Reduced 36.4%
15,200 $1.21 Million
Q1 2022

May 13, 2022

SELL
$57.98 - $93.5 $2.85 Million - $4.6 Million
-49,200 Reduced 76.4%
15,200 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$88.02 - $127.79 $1.98 Million - $2.88 Million
-22,500 Reduced 25.89%
64,400 $5.88 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $162.68 $4.26 Million - $5.64 Million
34,700 Added 66.48%
86,900 $11.2 Million
Q2 2021

Aug 13, 2021

BUY
$105.76 - $154.96 $5.52 Million - $8.09 Million
52,200 New
52,200 $7.96 Million
Q3 2019

Nov 14, 2019

SELL
$25.78 - $34.8 $289,071 - $390,212
-11,213 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$23.08 - $37.01 $682,867 - $1.1 Million
-29,587 Reduced 72.52%
11,213 $329,000
Q1 2019

May 14, 2019

SELL
$27.81 - $40.78 $1.24 Million - $1.82 Million
-44,600 Reduced 52.22%
40,800 $1.4 Million
Q4 2018

Feb 13, 2019

BUY
$28.91 - $50.0 $1.56 Million - $2.7 Million
54,000 Added 171.97%
85,400 $2.73 Million
Q3 2018

Nov 08, 2018

BUY
$30.85 - $50.65 $500,448 - $821,644
16,222 Added 106.88%
31,400 $1.51 Million
Q2 2018

Aug 13, 2018

BUY
$13.95 - $32.65 $211,733 - $495,561
15,178 New
15,178 $471,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.35B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.